Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: A retrospective cohort study and review of the literature

Autoimmunity Reviews

Volumn 10, Issue 8, 2011, Pages 490-494

  Arnson, Yoav ^a   Amital, Howard ^a   Agmon Levin, Nancy ^b   Alon, Danny ^a   Sánchez Castañón, María ^c   López Hoyos, Marcos ^c   Matucci Cerinic, Marco ^d   Szücs, Gabriella ^e   Shapira, Yinon ^b   Szekanecz, Zoltan ^e   Shoenfeld, Yehuda ^b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d AOUC   (Italy)

^e UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Diffusing lung capacity for carbon monoxide; Fibrosis; Interstitial lung disease; Systemic Sclerosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ANTINUCLEAR ANTIBODY; CARBON MONOXIDE; RHEUMATOID FACTOR;

ADULT; AGE; AGED; AUTOIMMUNE DISEASE; CAPILLAROSCOPY; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CUTANEOUS PARAMETERS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBROSIS; FORCED VITAL CAPACITY; HUMAN; LUNG ARTERY PRESSURE; LUNG CAPACITY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; REVIEW; RODNAN SKIN SCORE; SYSTEMIC SCLEROSIS; VITAMIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DISEASE PROGRESSION; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBROSIS; HUMANS; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SKIN TESTS; VITAMIN D;

EID: 79957645587     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.02.002     Document Type: Review

References (74)

1. Arnson Y., Amital H., Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007, 66:1137-1142.
2. Cantorna M.T., Munsick C., Bemiss C., Mahon B.D. 1, 25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000, 130:2648-2652.
3. Cantorna M.T., Mahon B.D. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 2004, 229:1136-1142.
4. Cantorna M.T. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol 2006, 92:60-64.
5. Holick M.F., Chen T.C., Lu Z., Sauter E. Vitamin D and skin physiology: a D-lightful story. J Bone Miner Res 2007, 22(Suppl 2):V28-V33.
6. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
7. Munger K.L., Zhang S.M., O'Reilly E., Hernan M.A., Olek M.J., Willett W.C., et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004, 62:60-65.
8. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006, 296:2832-2838.
9. Shimada A., Kanazawa Y., Motohashi Y., Yamada S., Maruyama T., Ikegami H., et al. Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese. J Autoimmun 2008, 30:207-211.
10. Vieira V.M., Hart J.E., Webster T.F., Weinberg J., Puett R., Laden F., et al. Association between residences in U.S. northern latitudes and rheumatoid arthritis: a spatial analysis of the Nurses' Health Study. Environ Health Perspect 2010, 118:957-961.
11. Oelzner P., Franke S., Muller A., Hein G., Stein G. Relationship between soluble markers of immune activation and bone turnover in post-menopausal women with rheumatoid arthritis. Rheumatology (Oxford) 1999, 38:841-847.
12. Patel S., Farragher T., Berry J., Bunn D., Silman A., Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007, 56:2143-2149.
13. Shapira Y., Agmon-Levin N., Shoenfeld Y. Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol 2010, 6:468-476.
14. Amital H., Szekanecz Z., Szucs G., Danko K., Nagy E., Csepany T., et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?. Ann Rheum Dis 2010, 69:1155-1157.
15. Hein G., Oelzner P. Vitamin D metabolites in rheumatoid arthritis: findings-hypotheses-consequences. Z Rheumatol 2000, 59(Suppl 1):28-32.
16. Wei J., Bhattacharyya S., Tourtellotte W.G., Varga J. Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy. Autoimmun Rev 2011, 10:267-275.
17. Bussone G., Mouthon L. Interstitial lung disease in systemic sclerosis. Autoimmun Rev 2011, 10:248-255.
18. Lambova S., Muller-Ladner U. Pulmonary arterial hypertension in systemic sclerosis. Autoimmun Rev 2010, 9:761-770.
19. Nussinovitch U., Shoenfeld Y. Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality. Autoimmun Rev 2011, 10:259-266.
20. Czompoly T., Simon D., Czirjak L., Nemeth P. Anti-topoisomerase I autoantibodies in systemic sclerosis. Autoimmun Rev 2009, 8:692-696.
21. Grossman C., Dovrish Z., Shoenfeld Y., Amital H. Do infections facilitate the emergence of systemic sclerosis?. Autoimmun Rev 2011, 10:244-247.
22. Randone S.B., Guiducci S., Cerinic M.M. Systemic sclerosis and infections. Autoimmun Rev 2008, 8:36-40.
23. Ranque B., Mouthon L. Geoepidemiology of systemic sclerosis. Autoimmun Rev 2010, 9:A311-A318.
24. Dieude P., Boileau C., Allanore Y. Immunogenetics of systemic sclerosis. Autoimmun Rev 2011, 10:282-290.
25. Oertelt S., Selmi C., Invernizzi P., Podda M., Gershwin M.E. Genes and goals: an approach to microarray analysis in autoimmunity. Autoimmun Rev 2005, 4:414-422.
26. Reveille J.D. The genetic basis of autoantibody production. Autoimmun Rev 2006, 5:389-398.
27. Baraut J., Michel L., Verrecchia F., Farge D. Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis. Autoimmun Rev 2010, 10:65-73.
28. Chizzolini C., Brembilla N.C., Montanari E., Truchetet M.E. Fibrosis and immune dysregulation in systemic sclerosis. Autoimmun Rev 2011, 10:276-281.
29. Caramaschi P., Dalla G.A., Ruzzenente O., Volpe A., Ravagnani V., Tinazzi I., et al. Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol 2010, 12:1419-1425.
30. Rios F.R., Fernandez R.C., Callejas Rubio J.L., Ortego C.N. Vitamin D deficiency in a cohort of patients with systemic scleroderma from the south of Spain. J Rheumatol 2010, 37:1355.
31. Vacca A., Cormier C., Piras M., Mathieu A., Kahan A., Allanore Y. Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J Rheumatol 2009, 36:1924-1929.
32. Calzolari G., Data V., Carignola R., Angeli A. Hypovitaminosis D in systemic sclerosis. J Rheumatol 2009, 36:2844.
33. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T.A., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
34. Gershwin M.E., Borchers A.T., Keen C.L. Phenotypic and functional considerations in the evaluation of immunity in nutritionally compromised hosts. J Infect Dis 2000, 182(Suppl 1):S108-S114.
35. Gruver A.L., Hudson L.L., Sempowski G.D. Immunosenescence of ageing. J Pathol 2007, 211:144-156.
36. Malafaia G., Serafim T.D., Silva M.E., Pedrosa M.L., Rezende S.A. Protein-energy malnutrition decreases immune response to Leishmania chagasi vaccine in BALB/c mice. Parasite Immunol 2009, 31:41-49.
37. Selmi C., Tsuneyama K. Nutrition, geoepidemiology, and autoimmunity. Autoimmun Rev 2010, 9:A267-A270.
38. Fernandes G., Yunis E.J., Miranda M., Smith J., Good R.A. Nutritional inhibition of genetically determined renal disease and autoimmunity with prolongation of life in kdkd mice. Proc Natl Acad Sci USA 1978, 75:2888-2892.
39. Fernandes G., Friend P., Yunis E.J., Good R.A. Influence of dietary restriction on immunologic function and renal disease in (NZB x NZW) F1 mice. Proc Natl Acad Sci USA 1978, 75:1500-1504.
40. Hagen K.B., Byfuglien M.G., Falzon L., Olsen S.U., Smedslund G. Dietary interventions for rheumatoid arthritis. Cochrane Database Syst Rev 2009, CD006400.
41. Calder P.C., Yaqoob P. Understanding omega-3 polyunsaturated fatty acids. Postgrad Med 2009, 121:148-157.
42. Calder P.C., Albers R., Antoine J.M., Blum S., Bourdet-Sicard R., Ferns G.A., et al. Inflammatory disease processes and interactions with nutrition. Br J Nutr 2009, 101(Suppl 1):S1-S45.
43. Galli C., Calder P.C. Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review. Ann Nutr Metab 2009, 55:123-139.
44. Ruxton C.H., Calder P.C., Reed S.C., Simpson M.J. The impact of long-chain n-3 polyunsaturated fatty acids on human health. Nutr Res Rev 2005, 18:113-129.
45. Rosell M., Wesley A.M., Rydin K., Klareskog L., Alfredsson L. Dietary fish and fish oil and the risk of rheumatoid arthritis. Epidemiology 2009, 20:896-901.
46. Simopoulos A.P. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002, 21:495-505.
47. Dawczynski C., Schubert R., Hein G., Muller A., Eidner T., Vogelsang H., et al. Long-term moderate intervention with n-3 long-chain PUFA-supplemented dairy products: effects on pathophysiological biomarkers in patients with rheumatoid arthritis. Br J Nutr 2009, 101:1517-1526.
48. Chodick G., Amital H., Shalem Y., Kokia E., Heymann A.D., Porath A., et al. Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study. PLoS Med 2010, 7:e1000336.
49. Louneva N., Huaman G., Fertala J., Jimenez S.A. Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin. Arthritis Rheum 2006, 54:1298-1308.
50. Fett J.D., Ansari A.A., Sundstrom J.B., Combs G.F. Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. Int J Cardiol 2002, 86:311-316.
51. Sundstrom J.B., Fett J.D., Carraway R.D., Ansari A.A. Is peripartum cardiomyopathy an organ-specific autoimmune disease?. Autoimmun Rev 2002, 1:73-77.
52. Bao B., Prasad A.S., Beck F.W., Snell D., Suneja A., Sarkar F.H., et al. Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients. Transl Res 2008, 152:67-80.
53. Prasad A.S. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J Infect Dis 2000, 182(Suppl 1):S62-S68.
54. Prasad A.S. Zinc in human health: effect of zinc on immune cells. Mol Med 2008, 14:353-357.
55. Beck F.W., Prasad A.S., Kaplan J., Fitzgerald J.T., Brewer G.J. Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol 1997, 272:E1002-E1007.
56. Bowlus C.L. The role of iron in T cell development and autoimmunity. Autoimmun Rev 2003, 2:73-78.
57. Recalcati S., Minotti G., Cairo G. Iron regulatory proteins: from molecular mechanisms to drug development. Antioxid Redox Signal 2010, 13:1593-1616.
58. Cutolo M., Otsa K., Uprus M., Paolino S., Seriolo B. Vitamin D in rheumatoid arthritis. Autoimmun Rev 2007, 7:59-64.
59. Cutolo M., Otsa K. Review: vitamin D, immunity and lupus. Lupus 2008, 17:6-10.
60. Cutolo M., Otsa K., Paolino S., Yprus M., Veldi T., Seriolo B. Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann Rheum Dis 2009, 68:446-447.
61. Cutolo M. Vitamin D and autoimmune rheumatic diseases. Rheumatology (Oxford) 2009, 48:210-212.
62. Pelajo C.F., Lopez-Benitez J.M., Miller L.C. Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev 2010, 9:507-510.
63. Prietl B., Pilz S., Wolf M., Tomaschitz A., Obermayer-Pietsch B., Graninger W., et al. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases?. Isr Med Assoc J 2010, 12:136-139.
64. Toubi E., Shoenfeld Y. The role of vitamin D in regulating immune responses. Isr Med Assoc J 2010, 12:174-175.
65. Motrich R.D., van E.E., Depovere J., Riera C.M., Rivero V.E., Mathieu C. Impact of vitamin D receptor activity on experimental autoimmune prostatitis. J Autoimmun 2009, 32:140-148.
66. Shimada A., Kanazawa Y., Motohashi Y., Yamada S., Maruyama T., Ikegami H., et al. Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese. J Autoimmun 2008, 30:207-211.
67. Zold E., Szodoray P., Gaal J., Kappelmayer J., Csathy L., Gyimesi E., et al. Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther 2008, 10:R123.
68. Hajas A., Sandor J., Csathy L., Csipo I., Barath S., Paragh G., et al. Vitamin D insufficiency in a large MCTD population. Autoimmun Rev 2010.
69. Wu P.W., Rhew E.Y., Dyer A.R., Dunlop D.D., Langman C.B., Price H., et al. 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum 2009, 61:1387-1395.
70. Oren Y., Shapira Y., Agmon-Levin N., Kivity S., Zafrir Y., Altman A., et al. Vitamin D insufficiency in a sunny environment: a demographic and seasonal analysis. Isr Med Assoc J 2010, 12:751-756.
71. Ginde A.A., Scragg R., Schwartz R.S., Camargo C.A. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 2009, 57:1595-1603.
72. Ginde A.A., Liu M.C., Camargo C.A. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009, 169:626-632.
73. Ginde A.A., Mansbach J.M., Camargo C.A. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009, 169:384-390.
74. Smith S.M., Mathews Oliver S.A., Zwart S.R., Kala G., Kelly P.A., Goodwin J.S., et al. Nutritional status is altered in the self-neglecting elderly. J Nutr 2006, 136:2534-2541.